Pharmacogenomics of hydroxyurea therapy and fetal hemoglobin levels in sickle cell anemia
- PMID: 35546339
- DOI: 10.2217/pgs-2022-0050
Pharmacogenomics of hydroxyurea therapy and fetal hemoglobin levels in sickle cell anemia
Keywords: hydroxyurea; pharmacogenetics; pharmacogenomics; sickle cell anemia.
Similar articles
-
Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.Am J Hematol. 2015 Jul;90(7):E138-9. doi: 10.1002/ajh.24027. Am J Hematol. 2015. PMID: 25851995 No abstract available.
-
Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea.PLoS One. 2013;8(2):e55709. doi: 10.1371/journal.pone.0055709. Epub 2013 Feb 7. PLoS One. 2013. PMID: 23409025 Free PMC article.
-
A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.Expert Rev Hematol. 2015 Oct;8(5):669-79. doi: 10.1586/17474086.2015.1078235. Epub 2015 Sep 1. Expert Rev Hematol. 2015. PMID: 26327494 Free PMC article.
-
Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.Pediatr Blood Cancer. 2011 Feb;56(2):177-81. doi: 10.1002/pbc.22754. Epub 2010 Sep 9. Pediatr Blood Cancer. 2011. PMID: 20830771 Free PMC article. Review.
-
Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.Am J Hematol. 2005 Mar;78(3):243-4. doi: 10.1002/ajh.20293. Am J Hematol. 2005. PMID: 15726590
Cited by
-
Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.Int J Mol Sci. 2024 Apr 12;25(8):4263. doi: 10.3390/ijms25084263. Int J Mol Sci. 2024. PMID: 38673849 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical